General anesthetic actions on norepinephrine, dopamine, and γ-aminobutyric acid transporters in stably transfected cells

Anesthesia and Analgesia

Volumn 95, Issue 4, 2002, Pages 893-899

  Shahani, Saira K ^a   Lingamaneni, Ratnakumari ^a   Hemmings Jr , Hugh C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; CARRIER PROTEIN; DOPAMINE TRANSPORTER; ETOMIDATE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; NORADRENALIN TRANSPORTER; PENTOBARBITAL; PROPOFOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENERAL ANESTHESIA; GENETIC TRANSFECTION; HUMAN; IC 50; KIDNEY CELL CULTURE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRIORITY JOURNAL; RAT; SWINE;

EID: 0036784760     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200210000-00019     Document Type: Article

References (41)

1. Richards C. What the actions of anesthetics on fast synaptic transmission reveal about the molecular mechanisms of anesthesia. Toxicol Lett 1998;100-1:41-50.
2. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993;16:73-93.
3. Gu H, Wall SC, Rudnick G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 1994;269:7124-30.
4. Keynan S, Suh Y-J, Kanner BI, Rudnick G. Expression of a cloned γ-aminobutyric acid transporter in mammalian cells. Biochemistry 1992;31:1974-9.
5. 3H]GBR-12935: a specific high affinity ligand for labeling the dopamine transport complex. Eur J Pharmacol 1985;107:289-90.
6. Larsson OM, Falch E, Schousboe A, Krogsgaard-Larsen P. GABA uptake inhibitors: kinetics and molecular pharmacology. Adv Biosci 1991;82:197-200.
7. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
8. Taheri S, Halsey MJ, Liu J, et al. What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg 1991;72:627-34.
9. Pavan I, Buglione E, Massiccio M, et al. Monitoring propofol serum levels by rapid and sensitive reversed-phase high-performance liquid chromatography during prolonged sedation in ICU patients. J Chromatogr Sci 1992;30:164-6.
10. Tonner PH, Poppers DM, Miller KW. The general anesthetic potency of propofol and its dependence on hydrostatic pressure. Anesthesiology 1992;77:926-31.
11. 2O and fentanyl. Acta Anaesthesiol Scand 1986; 30:159-63.
12. Cohen ML, Chan S-L, Way W-L, Trevor AJ. Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology 1973;39:370-6.
13. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994;367:607-14.
14. Xu F, Gainetdinov RR, Wetsel WC, et al. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 2000;3:465-71.
15. Giros B, Jaber M, Jones SR, et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379:606-12.
16. MacIver MB. General anesthetic actions on transmission at glutamate and GABA synapses. In: Biebuyck JF, Lynch CIII, Maze M, et al., eds. Anesthesia: biological foundations. New York: Lippincott-Raven, 1997:277-86.
17. 3H] acetylcholine, from rat cerebral cortex. J Neurochem 1989;53:962-5.
18. Bazil CW, Minneman KP. Effects of clinically effective concentrations of halothane on adrenergic and cholinergic synapses in rat brain in vitro. J Pharmacol Exp Ther 1989;248:143-8.
19. El-Maghrabi EA, Eckenhoff RG. Inhibition of dopamine transport in rat brain synaptosomes by volatile anesthetics. Anesthesiology 1993;78:750-6.
20. Keita H, Lecharny JB, Henzel D, et al. Is inhibition of dopamine uptake relevant to the hypnotic action of i.v. anaesthetics? Br J Anaesth 1996;77:254-6.
21. Minami K, Yanagihara N, Segawa K, et al. Inhibitory effects of propofol on catecholamine secretion and uptake in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol 1996;353:572-8.
22. Hara K, Yanagihara N, Minami K, et al. Dual effects of intravenous anesthetics on the function of norepinephrine transporters. Anesthesiology 2000;93:1329-35.
23. Tas PWL, Kress HG, Koschel K. Volatile Anaesthetika und n-Alkanole hemmen die Aufnahme von Noradrenalin in Phäochromozytom-Zellen. Anaesthesist 1987;36:340-4.
24. 14C]glutamate by brain slices. Brain Res 1974;67:546-8.
25. Mantz J, Lecharny JB, Laudenbach V, et al. Anesthetics affect the uptake but not the depolarization-evoked release of GABA in rat striatal synaptosomes. Anesthesiology 1995;82:502-11.
26. Larsen M, Haugstad TS, Berg-Johnsen J, Langmoen IA. Effect of isoflurane on release and uptake of γ-aminobutyric acid from cortical synaptosomes. Br J Anaesth 1998;80:634-8.
27. Liachenko S, Tang P, Somogyi G, Xu Y. Concentration-dependent isoflurane effects on depolarization-evoked glutamate and GABA outflows from mouse brain slices. Br J Pharmacol 1999;127:131-8.
28. Westphalen RI, Hemmings HC Jr. Effects of isoflurane and propofol on glutamate and GABA transporters in isolated cortical nerve terminals. Anesthesiology. In press.
29. Minchin MCW. The effect of anaesthetics on the uptake and release of γ-aminobutyrate and D-aspartate in rat brain slices. Br J Pharmacol 1981;73:681-9.
30. Kendall TJG, Minchin MCW. The effects of anaesthetics on the uptake and release of amino acid transmitters in thalamic slices. Br J Pharmacol 1981;75:219-27.
31. Smith DJ, Azzaro AJ, Zaldivar SB, et al. Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines. Neuropharmacology 1981; 20:391-6.
32. Hara K, Yanagihara N, Minami K, et al. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn Schmiedebergs Arch Pharmacol 1998;358:328-33.
33. Nishimura M, Sato K, Okada T, et al. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 1998;88:768-74.
34. Sugimura M, Kitayama S, Morita K, et al. Effects of volatile and intravenous anesthetics on the uptake of GABA, glutamate and dopamine by their transporters heterologously expressed in COS cells and in rat brain synaptosomes. Toxicol Lett 2001;123: 69-76.
35. Eckenhoff RG, Fagan D. Inhalation anaesthetic competition of high affinity cocaine binding sites in rat brain synaptosomes. Br J Anaesth 1994;73:820-5.
36. Kadota T, Yamaai T, Saito Y, et al. Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J Histochem Cytochem 1996;44:989-96.
37. Øye I, Paulsen O, Maurset A. Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 1992;260:1209-13.
38. Vuyk J. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol. J Clin Anesth 1997;9:23S-6.
39. Bohn LM, Xu F, Gainetdinov RR, Caron MG. Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci 2000;20:9040-5.
40. Zacny JP, Lichtor JL, Thompson W, Apfelbaum JL. Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesth Analg 1993;77:544-52.
41. Jansen KLR. Non-medical use of ketamine. BMJ 1993;306:601-2.